Pharmaceutical Technology\'s In the Lab eNewsletter-03-04-2020

March 04, 2020

Advanced technologies, such as artificial intelligence and synthetic biology, can be used to their full potential in upstream bioprocessing, provided that data and knowledge management can be effectively managed.

February 28, 2020

The new washer features a large loading capacity and a functional, compact design.

February 28, 2020

The partners will explore Dyadic’s C1 gene expression platform in conjunction with IIBR’s express gene sequences and targets to develop a potential vaccine candidate and monoclonal antibodies.

February 28, 2020

Eurofins DiscoverX partners with VelaLabs to enable VelaLabs to perform highly reproducible potency lot release assays under GLP/GMP conditions.

February 28, 2020

Under the agreement, ERS Genomics will license its gene-editing technology to Aelian Biotechnoloy to support its commercial functional genomic screening platform.

February 27, 2020

Water Street Healthcare Partners, a strategic investor that is focused on the healthcare industry, has agreed to invest in Solvias, a global pharmaceutical laboratory services business.

February 26, 2020

The decision was made after it was determined that many of the event’s largest stakeholders would be unable to travel to the conference due to the novel coronavirus outbreak.

February 17, 2020

The agency is taking steps to monitor the supply chain and assist in the development of treatments.

February 13, 2020

The Native Antigen Company has commercially introduced antigens that have been specifically derived from the Wuhan strain of novel coronavirus, now named Covid-19.

February 05, 2020

The knockout CHO K1 cell line will be used to support biotherapeutic R&D across a range of therapeutic indications.

February 02, 2020

Complex protein structures pose analytical difficulties that can be addressed by advanced mass spectrometry technologies and workflows, which can be used to comprehensively describe them.